National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 28637 [2021-11212]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 101 / Thursday, May 27, 2021 / Notices
Health, 5601 Fishers Lane, Room 3G62
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Eleazar Cohen, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G62, Rockville, MD
20852, (240) 669–5081, ecohen@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: May 21, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–11206 Filed 5–26–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: May 21, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Early Phase Clinical Trial
Units (EPCTU): Task Area D/Sample Task
Order D (N01).
Date: June 25, 2021.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G62A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Eleazar Cohen, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G62A, Rockville, MD
20852, (240) 669–5081, ecohen@
niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
VerDate Sep<11>2014
17:29 May 26, 2021
Jkt 253001
Emphasis Panel; Early Phase Clinical Trial
Units (EPCTU): Task Area E/Sample Task
Order E (N01).
Date: June 28, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G62A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Eleazar Cohen, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G62A, Rockville, MD
20852, (240) 669–5081, ecohen@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
[FR Doc. 2021–11212 Filed 5–26–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
[Docket Number DHS–2021–0023]
Generic Clearance for the Collection of
Qualitative Feedback on Agency
Service Delivery
Department of Homeland
Security (DHS).
ACTION: 60-Dsay notice and request for
comments; extension without change of
a currently approved Collection, 1601–
0014.
AGENCY:
The Department of Homeland
Security, will submit the following
Information Collection Request (ICR) to
the Office of Management and Budget
(OMB) for review and clearance in
accordance with the Paperwork
Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted until July 26, 2021.
This process is conducted in accordance
with 5 CFR 1320.1
ADDRESSES: You may submit comments,
identified by docket number Docket #
DHS–2021–0023, at:
Æ Federal eRulemaking Portal: https://
www.regulations.gov. Please follow the
instructions for submitting comments.
Instructions: All submissions received
must include the agency name and
docket number Docket # DHS–2021–
0023. All comments received will be
posted without change to https://
SUMMARY:
PO 00000
Frm 00113
Fmt 4703
Sfmt 4703
28637
www.regulations.gov, including any
personal information provided.
Docket: For access to the docket to
read background documents or
comments received, go to https://
ww.regulations.gov.
Executive
Order 12862 directs Federal agencies to
provide service to the public that
matches or exceeds the best service
available in the private sector. In order
to work continuously to ensure that our
programs are effective and meet our
customers’ needs, Department of
Homeland Security (hereafter ‘‘the
Agency’’) seeks to obtain OMB approval
of a generic clearance to collect
qualitative feedback on our service
delivery. By qualitative feedback we
mean information that provides useful
insights on perceptions and opinions
but are not statistical surveys that yield
quantitative results that can be
generalized to the population of study.
This collection of information is
necessary to enable the Agency to garner
customer and stakeholder feedback in
an efficient, timely manner, in
accordance with our commitment to
improving service delivery. The
information collected from our
customers and stakeholders will help
ensure that users have an effective,
efficient, and satisfying experience with
the Agency’s programs. This feedback
will provide insights into customer or
stakeholder perceptions, experiences
and expectations, provide an early
warning of issues with service, or focus
attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
Agency and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
Improving agency programs requires
ongoing assessment of service delivery,
by which we mean systematic review of
the operation of a program compared to
a set of explicit or implicit standards, as
a means of contributing to the
continuous improvement of the
program. The Agency will collect,
analyze, and interpret information
gathered through this generic clearance
to identify strengths and weaknesses of
current services and make
improvements in service delivery based
on feedback. The solicitation of
feedback will target areas such as:
Timeliness, appropriateness, accuracy
of information, courtesy, efficiency of
service delivery, and resolution of
issues with service delivery. Responses
SUPPLEMENTARY INFORMATION:
E:\FR\FM\27MYN1.SGM
27MYN1
]]>Agencies
[Federal Register Volume 86, Number 101 (Thursday, May 27, 2021)]
[Notices]
[Page 28637]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11212]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Early Phase Clinical Trial Units
(EPCTU): Task Area D/Sample Task Order D (N01).
Date: June 25, 2021.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G62A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room 3G62A, Rockville, MD
20852, (240) 669-5081, [email protected].
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Early Phase Clinical Trial Units
(EPCTU): Task Area E/Sample Task Order E (N01).
Date: June 28, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G62A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room 3G62A, Rockville, MD
20852, (240) 669-5081, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: May 21, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-11212 Filed 5-26-21; 8:45 am]
BILLING CODE 4140-01-P
